TY - JOUR
T1 - Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial) : trial protocol
AU - Chow, Josephine S. F.
AU - Boudville, N.
AU - Cho, Y.
AU - Palmer, S.
AU - Pascoe, E. M.
AU - Hawley, C. M.
AU - Reidlinger, D. M.
AU - Hickey, L. E.
AU - Stastny, R.
AU - Valks, A.
AU - Vergara, L.
AU - Movva, R.
AU - Kiriwandeniya, C.
AU - Candler, H.
AU - Mihala, G.
AU - Buisman, B.
AU - Equinox, K. L.
AU - Figueiredo, A. E.
AU - Fuge, T.
AU - Howard, K.
AU - Howell, M.
AU - Jaure, A.
AU - Jose, M. D.
AU - Lee, A.
AU - Miguel, S. S.
AU - Moodie, J. A.
AU - Nguyen, T. T.
AU - Pinlac, G.
AU - Reynolds, A.
AU - Saweirs, W. W. M.
AU - Steiner-Lim, Genevieve Z.
AU - TeWhare, B.
AU - Tomlins, M.
AU - Upjohn, M.
AU - Voss, D.
AU - Walker, R. C.
AU - Wilson, J.
AU - Johnson, D. W.
PY - 2023/12
Y1 - 2023/12
N2 - Background: Peritoneal dialysis (PD)‑related infections, such as peritonitis, exit site, and tunnel infections, substantially impair the sustainability of PD. Accordingly, PD‑related infection is the top‑priority research outcome for patients and caregivers. While PD nurse trainers teach patients to perform their own PD, PD training curricula are not standardized or informed by an evidentiary base and may offer a potential approach to prevent PD infections. The Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes (TEACH‑PD) trial evaluates whether a standardized training curriculum for PD nurse trainers and incident PD patients based on the International Society for Peritoneal Dialysis (ISPD) guidelines reduces PD‑related infections compared to usual training practices. Methods: The TEACH‑PD trial is a registry‑based, pragmatic, open‑label, multi‑center, binational, cluster‑randomized controlled trial. TEACH‑PD will recruit adults aged 18 years or older who have not previously undergone PD training at 42 PD treatment units (clusters) in Australia and New Zealand (ANZ) between July 2019 and June 2023. Clusters will be randomized 1:1 to standardized TEACH‑PD training curriculum or usual training practice. The primary trial out‑ come is the time to the first occurrence of any PD‑related infection (exit site infection, tunnel infection, or peritonitis). The secondary trial outcomes are the individual components of the primary outcome, infection‑associated catheter removal, transfer to hemodialysis (greater than 30 days and 180 days), quality of life, hospitalization, all‑cause death, a composite of transfer to hemodialysis or all‑cause death, and cost‑effectiveness. Participants are followed for a mini‑ mum of 12 months with a targeted average follow‑up period of 2 years. Participant and outcome data are collected from the ANZ Dialysis and Transplant Registry (ANZDATA) and the New Zealand Peritoneal Dialysis (NZPD) Registry. This protocol follows the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines. Discussion: TEACH‑PD is a registry‑based, cluster‑randomized pragmatic trial that aims to provide high‑certainty evidence about whether an ISPD guideline‑informed standardized PD training curriculum for PD nurse trainers and adult patients prevents PD‑related infections. Trial registration: ClinicalTrials.gov NCT03816111. Registered on 24 January 2019.
AB - Background: Peritoneal dialysis (PD)‑related infections, such as peritonitis, exit site, and tunnel infections, substantially impair the sustainability of PD. Accordingly, PD‑related infection is the top‑priority research outcome for patients and caregivers. While PD nurse trainers teach patients to perform their own PD, PD training curricula are not standardized or informed by an evidentiary base and may offer a potential approach to prevent PD infections. The Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes (TEACH‑PD) trial evaluates whether a standardized training curriculum for PD nurse trainers and incident PD patients based on the International Society for Peritoneal Dialysis (ISPD) guidelines reduces PD‑related infections compared to usual training practices. Methods: The TEACH‑PD trial is a registry‑based, pragmatic, open‑label, multi‑center, binational, cluster‑randomized controlled trial. TEACH‑PD will recruit adults aged 18 years or older who have not previously undergone PD training at 42 PD treatment units (clusters) in Australia and New Zealand (ANZ) between July 2019 and June 2023. Clusters will be randomized 1:1 to standardized TEACH‑PD training curriculum or usual training practice. The primary trial out‑ come is the time to the first occurrence of any PD‑related infection (exit site infection, tunnel infection, or peritonitis). The secondary trial outcomes are the individual components of the primary outcome, infection‑associated catheter removal, transfer to hemodialysis (greater than 30 days and 180 days), quality of life, hospitalization, all‑cause death, a composite of transfer to hemodialysis or all‑cause death, and cost‑effectiveness. Participants are followed for a mini‑ mum of 12 months with a targeted average follow‑up period of 2 years. Participant and outcome data are collected from the ANZ Dialysis and Transplant Registry (ANZDATA) and the New Zealand Peritoneal Dialysis (NZPD) Registry. This protocol follows the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines. Discussion: TEACH‑PD is a registry‑based, cluster‑randomized pragmatic trial that aims to provide high‑certainty evidence about whether an ISPD guideline‑informed standardized PD training curriculum for PD nurse trainers and adult patients prevents PD‑related infections. Trial registration: ClinicalTrials.gov NCT03816111. Registered on 24 January 2019.
UR - https://hdl.handle.net/1959.7/uws:78641
U2 - 10.1186/s13063-023-07715-0
DO - 10.1186/s13063-023-07715-0
M3 - Article
SN - 1745-6215
VL - 24
JO - Trials
JF - Trials
M1 - 730
ER -